Hepatitis C virus and cardiovascular: A review

Area of Science:

• Hepatology
• Cardiology
• Virology

Background:

• Chronic hepatitis C virus (HCV) infection is a systemic illness linked to cirrhosis, extrahepatic disorders, and metabolic issues like insulin resistance.
• Emerging evidence suggests a connection between HCV infection and increased cardiovascular risk, with potential benefits from viral eradication.
• However, conflicting data and the high prevalence of both conditions create uncertainty regarding a direct association.

Purpose of the Study:

• To review existing data on the relationship between HCV infection and cardiovascular risk.
• To explore potential mechanisms linking HCV to vascular damage.
• To assess the impact of HCV viral eradication on cardiovascular outcomes.

Main Methods:

• Systematic review of current literature.
• Analysis of studies investigating HCV infection and cardiovascular alterations.
• Evaluation of evidence on mechanisms and outcomes of HCV treatment.

Main Results:

• Accumulating evidence suggests HCV infection may elevate cardiovascular risk.
• Potential mechanisms linking HCV to vascular damage have been identified.
• Conflicting results exist, necessitating further investigation.

Conclusions:

• The precise role of HCV in cardiovascular alterations requires definitive clarification.
• The impact of viral eradication on cardiovascular outcomes needs further study.
• New, effective antiviral therapies make this research timely.